Investor
Centre
LATEST RESULTS
AT A GLANCE
Revenue increased by 12,5% to R350,5 million (F2023: R311,7 million)
EBITDA, impairments and earnings from associate increased by 95,5% to R48,3 million (F2023: R24,7 million)
Earnings per share increased by more than 100,0% to 1,0 cents per share (F2023: loss of 0,7 cents per share)
Headline earnings per share increased by more than 100,0% to 1,3 cents per share (F2023: loss of 0,1 cents per share)
Total equity increased by 7,7% to R114,7 million (F2023: R106,4 million)
Net asset value per share increased by 7,8% to 13,9 cents per share (F2023: 12,9 cents per share)
Net tangible asset value per share increased by 18,4% to 11,6 cents per share (F2023: 9,8 cents per share)
Current acid ratio increased by 28,6% to 0,9:1 (F2023: 0,7:1)
Acid test ratio increased by 50%Â to 0,3:1Â (F2023: 0,2:1)
Financial results and
integrated reporting
along with all financial information are available to
download from the Investor Centre section.